Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for myeloid/lymphoid neoplasms associated with eosinophilia and abnormality of PDGFRA, PDGFRB, FGFR1 or JAK2 has been reported in the published literature.
No clinical trials have been registered for myeloid/lymphoid neoplasms associated with eosinophilia and abnormality of PDGFRA, PDGFRB, FGFR1 or JAK2.
306 publications have been identified in PubMed for myeloid/lymphoid neoplasms associated with eosinophilia and abnormality of PDGFRA, PDGFRB, FGFR1 or JAK2. Kisho has analyzed 216 by research type. Research spans Basic Science / Preclinical (55%), Review / Meta-Analysis (12%), and Epidemiology / Natural History (10%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 118 |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 4:39 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
55%
Research summaries | 26 | 12% |
Disease patterns and progression | 22 | 10% |
Patient case studies | 14 | 6% |
Clinical study results | 14 | 6% |
New treatment approaches | 10 | 5% |
Testing and diagnosis research | 8 | 4% |
Other research | 4 | 2% |
Ellis MH (2026). [PMID: 41902804](https://pubmed.ncbi.nlm.nih.gov/41902804/). *Mayo Clin Proc*. [Review / Meta-Analysis]
Li C (2026). [PMID: 41870292](https://pubmed.ncbi.nlm.nih.gov/41870292/). *Clin Invest Med*. [Basic Science / Preclinical]
Larsen MK (2026). [PMID: 41198600](https://pubmed.ncbi.nlm.nih.gov/41198600/). *J Intern Med*. [Epidemiology / Natural History]
Collins S (2026). [PMID: 42074482](https://pubmed.ncbi.nlm.nih.gov/42074482/). *Genes (Basel)*. [Review / Meta-Analysis]
Zhou W (2026). [PMID: 41308854](https://pubmed.ncbi.nlm.nih.gov/41308854/). *Eur J Pharmacol*. [Clinical Trial Publication]
Shi YX (2026). [PMID: 41477983](https://pubmed.ncbi.nlm.nih.gov/41477983/). *Phytomedicine*. [Basic Science / Preclinical]
Yin TT (2026). [PMID: 41651988](https://pubmed.ncbi.nlm.nih.gov/41651988/). *Oncogene*. [Basic Science / Preclinical]
Geller S (2026). [PMID: 41296329](https://pubmed.ncbi.nlm.nih.gov/41296329/). *JAMA Dermatol*. [Case Report / Case Series]
Carter PR (2026). [PMID: 41433101](https://pubmed.ncbi.nlm.nih.gov/41433101/). *JCI Insight*. [Basic Science / Preclinical]
Bartalucci N (2026). [PMID: 41335026](https://pubmed.ncbi.nlm.nih.gov/41335026/). *Am J Hematol*. [Case Report / Case Series]